1. Home
  2. PERF vs CABA Comparison

PERF vs CABA Comparison

Compare PERF & CABA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Perfect Corp.

PERF

Perfect Corp.

HOLD

Current Price

$1.81

Market Cap

187.4M

Sector

Technology

ML Signal

HOLD

Logo Cabaletta Bio Inc.

CABA

Cabaletta Bio Inc.

HOLD

Current Price

$2.34

Market Cap

200.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PERF
CABA
Founded
2015
2017
Country
Taiwan
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
187.4M
200.2M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
PERF
CABA
Price
$1.81
$2.34
Analyst Decision
Strong Buy
Analyst Count
0
8
Target Price
N/A
$13.50
AVG Volume (30 Days)
112.2K
3.0M
Earning Date
10-28-2025
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
8.89
N/A
EPS
0.06
N/A
Revenue
$66,900,999.00
N/A
Revenue This Year
$16.39
N/A
Revenue Next Year
$14.80
N/A
P/E Ratio
$32.93
N/A
Revenue Growth
14.47
N/A
52 Week Low
$1.51
$0.99
52 Week High
$3.44
$5.46

Technical Indicators

Market Signals
Indicator
PERF
CABA
Relative Strength Index (RSI) 47.74 48.03
Support Level $1.67 $2.01
Resistance Level $1.75 $2.69
Average True Range (ATR) 0.08 0.21
MACD 0.01 0.01
Stochastic Oscillator 51.85 48.53

Price Performance

Historical Comparison
PERF
CABA

About PERF Perfect Corp.

Perfect Corp is engaged in the beauty and fashion tech revolution, providing omni-channel integrated solutions. The company runs a hybrid business model of direct consumer business (B2C business) and enterprise business (B2B business). For B2C businesses, the company offers six mobile apps under the "YouCam" suite, along with one online editing service tool, YouCam Online Editor, featuring AI and AR technologies. For B2B businesses, the company offers AI and AR-powered solutions tailored for the beauty and fashion industry. Geographically, the company has a presence in the United States, Americas-other, France, Japan, and Others. The company generates the majority of its revenue from the United States.

About CABA Cabaletta Bio Inc.

Cabaletta Bio Inc is a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies and exploring their potential to provide a deep and durable, perhaps curative, treatment for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes Chimeric AutoAntibody Receptor, or CAART cells, that are designed to selectively bind and eliminate only specific B cells that produce disease-causing autoantibodies, or pathogenic B cells, while sparing normal B cells. Its CABA platform encompasses two strategies: CARTA (chimeric antigen receptor T cells for autoimmunity) and CAART (chimeric autoantibody T cells) that have the potential to be applied across a broad range of autoimmune diseases.

Share on Social Networks: